The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).
 
Simon Gollins
Honoraria - Merck Serono
 
David Sebag-Montefiore
No Relationships to Disclose
 
Richard Adams
Honoraria - Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Merck Serono; Roche/Genentech; Sanofi
Speakers' Bureau - Merck Serono; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Roche/Genentech; Sanofi
 
Mark P. Saunders
No Relationships to Disclose
 
Robert Grieve
No Relationships to Disclose
 
Nigel Scott
No Relationships to Disclose
 
Gina Brown
No Relationships to Disclose
 
Philip Quirke
No Relationships to Disclose
 
Laura Butlin
No Relationships to Disclose
 
Ruby Ray
No Relationships to Disclose
 
Gareth Griffiths
No Relationships to Disclose
 
Chris Hurt
No Relationships to Disclose